US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist
  • 4.9900
  • -1.0850-17.86%
Close Apr 26 16:00 ET
  • 4.8608
  • -0.1292-2.59%
Post 19:59 ET
3.79MMarket Cap-19P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ZyVersa Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-32.92

+81.44%
Analyst Rating

Buy

Apr 28, 2024

ZyVersa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

ZyVersa Therapeutics Earnings Reports

  • ZyVersa Therapeutics | 10-K: Annual report

    Mar 25 08:03 ET

  • ZyVersa Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:34 ET

  • ZyVersa Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 21, 2023 16:03 ET

  • ZyVersa Therapeutics | 10-Q: Quarterly report

    May 12, 2023 06:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg